<DOC>
	<DOCNO>NCT02138825</DOCNO>
	<brief_summary>To evaluate efficacy safety 26-weeks treatment riociguat vs. placebo patient symptomatic PH ( pulmonary hypertension ) associate IIP ( idiopathic interstitial pneumonia ) .</brief_summary>
	<brief_title>Efficacy Safety Riociguat Patients With Symptomatic Pulmonary Hypertension ( PH ) Associated With Idiopathic Interstitial Pneumonias ( IIP )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Lung Diseases , Interstitial</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<criteria>Men woman age ≥18 ≤80 year Diagnosed one following ( confirm use multidisciplinary approach , per ATS ( American Thoracic Society ) / ERS ( European Respiratory Society ) / JRS ( Japanese Respiratory Society ) / ALAT ( Latin American Thoracic Association ) guideline : Major IIPs ( idiopathic interstitial pneumonia ) diagnosis suspect one following : Idiopathic pulmonary fibrosis Idiopathic nonspecific interstitial pneumonia Respiratory bronchiolitisinterstitial lung disease Desquamative interstitial pneumonia Cryptogenic organize pneumonia Acute interstitial pneumonia Rare IIPs diagnosis one following : Idiopathic lymphoid interstitial pneumonia Idiopathic pleuroparenchymal fibroelastosis Unclassifiable idiopathic interstitial pneumonia Forced Vital Capacity ( FVC ) ≥ 45 % 6MWD ( 6 minute walk distance ) ≥ 150 ≤ 450 { stable O2 ( oxygen ) supplementation via nasal cannula } Diagnosis PH ( pulmonary hypertension ) confirm right heart catheter ( RHC ) ( mean artery pulmonary artery pressure ) mPAP ≥ 25 mmHg ( pulmonary artery wedge pressure ) PAWP ≤15 mmHg rest Systolic blood pressure ( SBP ) ≥ 95 mmHg sign symptom hypotension WHO functional class IIIV Women childbearing potential include study pregnancy test negative . Women childbearing potential must agree use adequate contraception sexually active . 'Adequate contraception ' define combination least 2 effective method birth control , least one physical barrier ( e.g . condom hormonal contraception implant combine oral contraceptive , certain intrauterine device ) . Adequate contraception require signing informed consent form 4 week last study drug administration Known significant leave heart disease : Pulmonary venous hypertension indicate baseline pulmonary capillary wedge pressure &gt; 15 mmHg Symptomatic coronary artery disease Systolic leftventricular dysfunction leave ventricular ejection fraction ( LVEF ) &lt; 45 % Active state hemoptysis pulmonary hemorrhage , include event manage bronchial artery embolization Any history bronchial artery embolization massive hemoptysis within 3 month prior screen . Massive hemoptysis define acute bleeding &gt; 240 mL 24hour period recurrent bleed &gt; 100 mL/d several day Difference &gt; 15 % eligibility baseline 6MWD test Forced expiratory volume one second ( FEV1 ) / Forced Vital Capacity ( FVC ) &lt; 0.65 bronchodilator administration Initiation cytotoxic , immunosuppressive , cytokine modulate therapy initiate within 3 month prior screen . Such agent might include . azathioprine , cyclophosphamide , corticosteroid , etanercept , tumor necrosis factor alpha ( TNFα ) inhibitor others Any specific treatment ( pulmonary arterial hypertension ) PAH/PH ( pulmonary hypertension ) within 3 month prior screen Concomitant use follow medication : nitrate ( nitric oxide ) NO donor ( amyl nitrite ) form , phosphodiesterase 5 inhibitor ( sildenafil , tadalafil , vardenafil ) nonspecific phosphodiesterase ( PDE ) inhibitor ( theophylline , dipyridamole ) , Pregnant woman ( i.e . positive pregnancy test sign pregnancy ) , breast feeding woman , woman childbearing potential use adequate contraception ( define aforementioned inclusion criterion ) willing agree 4 weekly pregnancy test Visit 1 ( first administration study drug ) onwards 4 week last study drug intake</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>